Navigation Links
NuVasive to Present at Thomas Weisel Partners Healthcare Conference
Date:8/22/2007

SAN DIEGO, Aug. 22 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Kevin O'Boyle, Executive Vice President and Chief Financial Officer, is scheduled to present at the Thomas Weisel Partners Healthcare Conference at the Four Season Hotel, Boston, MA, on Thursday, September 6, 2007, at 9:45 a.m. ET.

A live Web cast of the presentation will be available online from the investor relations page of the Company's corporate Web site at http://www.nuvasive.com. After the live Web cast, the presentation will remain available on NuVasive's Web site, http://www.nuvasive.com, for 30 days.

About NuVasive

NuVasive is a medical device company focused on the design, development and marketing of products for the surgical treatment of spine disorders. The Company's product portfolio is focused on applications in the over $3.6 billion U.S. spine fusion market. The Company's current principal product offering includes a minimally disruptive surgical platform called Maximum Access Surgery, or MAS(TM), as well as a growing offering of cervical and motion preservation products.

The MAS platform offers advantages for both patients and surgeons such as reduced surgery and hospitalization time and faster recovery. MAS combines three categories of current product offerings: NeuroVision(R) a proprietary software-driven nerve avoidance system; MaXcess(R) a unique split-blade design retraction system; and specialized implants, like SpheRx(R) and CoRoent(R), that collectively minimize soft tissue disruption during spine surgery while allowing maximum visualization and surgical reproducibility. NuVasive's product offering is also focused on cervical internal fixation products and its R&D pipeline emphasizes both MAS and mo
'/>"/>

SOURCE NuVasive, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Amplification of genome-representative DNA from limited sources with GenomePlex WGA technology for use in genetic alterations studies
2. Wisconsin firms to present at Cleantech venture capital event
3. New Sonic Foundry search engine finds words, phrases in video presentations
4. Lone Wisconsin firm to present at InvestMidwest
5. Sonic Foundry creates search engine for 7,000 expert video presentations
6. InvestMidWest calls for business presentations
7. Wicab to present BrainPort at Boston conference
8. Three more Wisconsin firms to present at venture forum
9. Six Wisconsin firms to present at BIO Mid-America VentureForum
10. New Health and Human Services representative for Midwest
11. Top 20 big pharmas represent majority of world pharma market

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...st people would like to be able to charge their ce...nd not too often. A recent discovery made by UC Sa...sed supercapacitors that could do just this. , ...Letters , Prabhakar Bandaru, a professor in the UC...ing, along with graduate student Mark Hoefer, have...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)... , ,, BETHESDA, Md., Nov. 19 /PRNewswir...X ), an innovator in biotechnology for diabetes th...consulting services to food, supplement, biotechno... it closed the previously reported $6.3 million re...rs of 2,760,870 shares of its common stock and war...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
Breaking Biology Technology:Nanotube defects equal better energy and storage systems 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...ny Promega announced on Tuesday a settlement of a ... had been pending before the U.S. District Court i...Promega will hold a worldwide non-exclusive licens...based around Benitec,s DNA-directed RNA interferen...a combined payment of cash and continued royalties...
...ailer Menards has selected a series of technolog...., the company said Wednesday. , ,Menards deploye...ions software and the Teradata Retail Logical Date...ta marts that could not provide the information bu...ccurate or out-of-date information, according to t...
...of Wisconsin has received a five-year, $1 million ...sthetics protect the human heart against injury fr...g during heart surgery. The college also has recei...ies. , ,Zeljko Bosnjak, Ph.D., professor and vice ...logy, is the principal investigator. , ,A team of ...
Other Biology Technology:
(Date:11/20/2009)...surements of plasma lipoprotein concentrations det... (NMR), researchers led by Daniel Chasman at Brigh... in Boston, MA, the Framingham Heart Study in Fram... Sweden and Oxford, England performed genetic asso...296 women of European ancestry from the Women,s Ge...
(Date:11/20/2009)...20, 2009) Scientists from the Marine Biogeochemis...al Research Laboratory (NRL) organized and led a t...Arctic expedition to initiate methane hydrate expl...ial variation of sediment contribution to Arctic c...Cutter Polar Sea as a research platform, three cro...
(Date:11/20/2009)...s in coal-tar-based sealcoats in parking lots may ...ng to a USGS study. PAHs or polycyclic aromatic ...al and tar deposits, and can have toxic effects. I...ouse dust; however, the specific sources of these ...hat dust from indoor areas near parking lots with ...
Breaking Biology News(10 mins):Genetic analysis helps dissect molecular basis of cardiovascular disease 2International expedition investigates climate change, alternative fuels in Arctic 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Planets nitrogen cycle overturned by tiny ammonia eater of the seas 10200 1Planets nitrogen cycle overturned by tiny ammonia eater of the seas 10200 2Planets nitrogen cycle overturned by tiny ammonia eater of the seas 10200 3Eleven Health 26amp 3B Consumer Groups Urge Federal Court to Reject Tobacco Companies Lawsuit Against FDA Tobacco Regulation Law 58604 1Eleven Health 26amp 3B Consumer Groups Urge Federal Court to Reject Tobacco Companies Lawsuit Against FDA Tobacco Regulation Law 58604 2Revolutionary B School Building Named for Healthcare Entrepreneur Alan B Miller To Be Dedicated 58601 1Revolutionary B School Building Named for Healthcare Entrepreneur Alan B Miller To Be Dedicated 58601 2Revolutionary B School Building Named for Healthcare Entrepreneur Alan B Miller To Be Dedicated 58601 3
...clerosis (MS), neuroradiologists and neurologists ...urg have been able to visualize inflammatory tissu...up to now, with the aid of a new contrast medium, ... scientists have published their results in the on...n . , In particular at the early stage of the di...
...ers report this week that chronic exposure to estr...ome cognitive functions. Rats exposed to a steady ... working memory and response inhibition, the resea... the journal Behavioral Neuroscience . , The res...cts of estradiol on activities mediated by the pre...
...covers New Fraud Behavior Patterns, SAN DIEGO, Ju...d identity intelligence, today released the result...which provides an unprecedented,analysis of the cr...e of,identities stolen from the workplace by emplo...nderstanding of the harm resulting from an interna...
Other Biology News:Multiple Sclerosis: new MRI contrast medium enables early diagnosis in animal model 2Chronic exposure to estrogen impairs some cognitive functions 2Chronic exposure to estrogen impairs some cognitive functions 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 2ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 3ID Analytics Study Reveals Employees' Criminal Misuse of Stolen Identities 4
Mouse Anti-PPP4C Polyclonal Antibody, Unconjugated from Abnova Corporation
...rs maximum application versatility for sample prep...g. Its active heating/cooling function has greatly...ranges. Five different thermoblocks, which can eac...or: 0.5 ml, 1.5 ml, and 2.0 ml volumes; microplate...
Mouse Anti-Human PDE2A Monoclonal Antibody, Unconjugated, Clone 4F4 from Abnova Corporation
...reactivity of an antibody against various proteins...nts or antigen carriers. The array contains spots ...llulose membrane. Application: Determination of an... of purified antibodies, selection of suitable blo...
Biology Products: